Familial Hypercholesterolemia, and Elevated Triglycerides: Lipid Management in Clinical Practice

Lipid Management in Clinical Practice Familial Hypercholesterol, the genetic condition that causes high LDL cholesterol levels, may lead to early heart attacks or heart disease If undiagnosed or untreated. Guest Susan Halli Demeter, DNP, CNP, NP, of the Mayo Clinic, describes diagnosis, heterozygous and homozygous versions, treatments, and the importance of genetic screening for family members.

Read More

Homozygous Familial Hypercholesterolemia (HoFH): Patient Perspectives

Join Dr. Baum and Allison Jamison as they explore Homozygous Familial Hypercholesterolemia (HoFH) and HOFH patient perspectives. Dr. Baum shares about the etiology, prevalence, signs, symptoms, and the value of shared decision-making in testing and treatment. HoFH patient Allison Jamison shares her journey to diagnosis and its impact on her family.

Read More

Lipoprotein(a) and ASCVD Risk

Dr. Marlys Koschinsky describes Lipoprotein(a) and the increased risk for atherosclerotic cardiovascular disease (ASCVD). Join Dr. Koschinsky as she discusses measurement practices, the genetic link to Lipoprotein(a), and future treatment opportunities. This course also takes learners through a case study to explain elevated Lipoprotein(a) risk and initial diagnosis. 

Read More

The Role of Non-Statin Therapies in Optimal Cholesterol Management

Join Dr. Lundberg for this online course on non-statin therapies in optimal cholesterol management. This 1-hour course explores residual atherosclerotic cardiovascular disease risks and solutions for closing the treatment gap. Dr. Lundberg explains statin side effects, intolerance, and strategies to increase medication compliance. Additionally, this course explores the undertreatment risk of Familial Hyperlipidemia.  

Read More

Improving Adherence to Cholesterol-lowering Therapies

Join Lynne Braun, PhD, CNP, FPCNA, FAHA, FAANP, FNLA, FAAN  as she explores adherence to cholesterol-lowering therapies through patient-centered care. Dr. Braun will discuss cultural concerns along with health disparities that may affect adherence and provides resources to overcome barriers, such as costs of medications and complex treatment regimens. 

Read More

Transitioning from Acute to Chronic Lipid Management

Join Dr. Saseen as he reviews chronic lipid management techniques. Dr. Saseen discusses patient and family education techniques and possible social determinants of health barriers. The course then examines medications and health conditions that can increase cholesterol and reviews discharge planning with treatment adherence in mind.    

Read More

Non-Statin Therapies for Lipid Management

Susan Halli-Demeter, RN, DNP, CLS reviews the benefits of non-statin, LDL-C-lowering therapies for patients with very high-risk atherosclerotic cardiovascular disease (ASCVD) and severe hypercholesterolemia.

Read More

2021 Pharmacology Sessions

Clinical management of chronic cardiovascular disease is a key component of the work of advanced practice nurses and RNs in the cardiology and primary care settings. This annual pharmacology CE program was designed to meet the clinical practice and recertification needs of these clinicians. This 2021 curriculum includes a comprehensive approach to pharmacology in: The…

Read More